Fulcrum Therapeutics, Inc.

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) between March 3, 2022 and March 8, 2023, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 27, 2023.

If you purchased Fulcrum securities and would like to join the action, please click “Join This Class Action.”

Class Period:March 3, 2022 through March 8, 2023


18 Days
If you purchased Fulcrum securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Details of the case:

The Complaint alleges that defendants misled investors and/or failed to disclose that:

  • the preclinical data submitted in support of FTX-6058 (a prospective drug for the potential treatment of sickle-cell disease) showed safety concerns regarding potential hematological malignancies;
  • the foregoing safety concerns increased the likelihood that the U.S. Food and Drug Administration (“FDA”) would place a clinical hold on preclinical studies of FTX-6058;
  • accordingly, the Company had overstated FTX 6058’s clinical and/or commercial prospects; and
  • as a result, the Company’s public statements were materially false and misleading at all relevant times.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Follow us on:
Company Name: Fulcrum Therapeutics, Inc.
Stock Symbol: FULC
Class Period: March 3, 2022 through March 8, 2023
Court: United States District Court for the District of New Jersey

Why Rosen Law

The Rosen Law Firm has been ranked among the top 4 law firms each year since 2013 for the number of successful securities class actions on behalf of investors. In 2019 alone, our firm recovered $438 million for investors.

Investors should carefully identify and select experienced counsel with a track record of success leading securities class actions. Often other firms issue press releases about class actions yet do not have comparable experience or resources.

Institutional Shareholders Services ranked the Rosen Law Firm # 1 for the number of securities class action recoveries in 2017.

The Rosen Law Firm represents investors throughout the globe. Our mission is to prosecute securities fraud class actions and protect shareholders’ rights.

Scroll to Top